Blockchain Registration Transaction Record

Ace Therapeutics Unveils End-to-End Pain Drug Development Solutions

Ace Therapeutics announces end-to-end preclinical analgesic drug development services with validated in vivo pain models, accelerating pain therapeutic research for pharmaceutical and biotech clients.

This news matters because chronic pain affects millions worldwide, and developing safe, effective analgesics is a critical unmet need. Ace Therapeutics' comprehensive preclinical services—from validated pain models to safety assessment—accelerate drug discovery, potentially bringing new pain treatments to patients faster. By offering standardized and customized approaches, the company reduces research risks and costs for pharmaceutical and biotech firms, ultimately impacting the pace of innovation in pain management.